The case for high-dose dexamethasone suppression testing preoperatively in aldosterone-producing adenoma to exclude cosecretion of cortisol.
Gordon
Richard D
RD
Department of Cardiology, Greenslopes Hospital, Greenslopes, Australia. gordon.rd@bigpond.com
D000236:Adenoma / Q000378:metabolism*; D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000450:Aldosterone / Q000378:metabolism*; D003480:Cushing Syndrome / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D006929:Hyperaldosteronism / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012084:Renin-Angiotensin System / Q000502:physiology
D005938:Glucocorticoids; D000450:Aldosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone